Bavarian Nordic Beats Q3 Revenue Expectations
9 Articles
9 Articles
Bavarian Nordic sells rabies vaccines worth 886 million kroner in three months. This raises sales above analysts' expectations
BT
berlingske.dkThe company Bavarian Nordic has increased revenue and reduced production costs in the third quarter.
C25 shares fall slightly shortly after opening in Friday's trading. The index is down about 0.1 percent from the morning. Here are three stocks in focus: Bavarian Nordic: +1.00 percent. Vaccine company Bavarian Nordic exceeds analysts' expectations in the third quarter measured on the top line.
Det danske medicalselskab Bavarian Nordic, the ligger i Hellerup, kom ud af tredje kvartal med et overskud på 447 millioner kroner, viser kvartalsregnskabet, som selskabet har antöffentliggjort fredag tomorrow. Overskuddet skyldes blandt andet voksende omsætning og lavere omkostninger.
The company Bavarian Nordic had a profit of 447 million kroner in the third quarter, according to accounts.
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
